learning from experience
News archive
reading is everything
News
Lorem ipsum dolor sit amet, conetur adiping elit Lorem ipsum dolor sit amet, cons ectetur adipiscing elit Lorem ipsum dolor sit altmet, conse ctetur adipiscing elit aloma lomiur off silder tolos. Lorem ipsum dolor sitlor amet, conetur adiping elit Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Archives

Cost-effectiveness of Debrichem in managing hard-to-heal venous leg ulcers in the UK
Objective: To estimate whether the topical debriding agent, Debrichem, could potentially afford the UK’s National Health Service (NHS) a cost-effective intervention for the management of
DebX Medical: The Effectiveness of Debrichem on In Vitro Biofilms Report
All testing was performed in triplicate and testing was completed twice, separated by 2 weeks apart. This was to ensure reproducibility (Parker et al., 2018).

SA Introduction Letter
“If biofilms keep chronic wounds from healing, then Debrichem® is the solution” It is with great pride and anticipation that Debx Africa (Pty) Ltd are

Licence To Manufacture In Terms Of Section 22c(1)(B)
This licence authorises manufacture by the licence holder named; if the business should change hands, the company or person taking over the business will have

Licence To Manufacture Medical Devices
The licence holder and the persons described and named in Annexure 1 shall at all times ensure that all medical devices distributed, irrespective of its

Case Report Form
Within one minute of topical application of a red gel intends to facilitate the removal of unhealthy tissue. The semi fluid substance containing an acid

Case Study : 79-year-old female with a vasculitic ulcer on the right forefoot.
The wound had been present for 6 weeks when the patient entered the clinic for DEBRICHEM treatment. The lesion on the right forefoot was severely

Case Study : 62-year-old female with a venous leg ulcer on the ankle.
After full granulation was referred to another center for skin graft and the list for follow up. The patient entered the clinic with a chronic

Case Study : 51-year-old female with a vasculitic Ulcer on the lower right leg.
Read More

DEBx Medical receives Australian TGA approval for DEBRICHEM
Rotterdam, The Netherlands, March 19, 2021 – In early February, we finally obtained our ISO 13485:2016 certificate and our CE-certificate for DEBRICHEM. DEBRICHEM is a topical desiccantion gel for chemical